• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病小鼠永生化主动脉内皮细胞中球三糖神经酰胺调节及酶摄取的分子基础。

Molecular basis for globotriaosylceramide regulation and enzyme uptake in immortalized aortic endothelial cells from Fabry mice.

作者信息

Meng Xing-Li, Day Taniqua S, McNeill Nathan, Ashcraft Paula, Frischmuth Thomas, Cheng Seng H, Liu Zhi-Ping, Shen Jin-Song, Schiffmann Raphael

机构信息

Institute of Metabolic Disease, Baylor Research Institute, 3812 Elm Street, Dallas, TX, 75226, USA.

Greenovation Biotech GmbH, Freiburg, Germany.

出版信息

J Inherit Metab Dis. 2016 May;39(3):447-455. doi: 10.1007/s10545-016-9920-6. Epub 2016 Mar 10.

DOI:10.1007/s10545-016-9920-6
PMID:26960552
Abstract

Fabry disease is caused by deficient activity of α-galactosidase A and subsequent intracellular accumulation of glycosphingolipids, mainly globotriaosylceramide (Gb3). Vascular endothelial cells may play important roles in disease pathogenesis, and are one of the main target cell types in therapeutic interventions. In this study, we generated immortalized aortic endothelial cell lines from a mouse model of Fabry disease. These cells retained endothelial cell-specific markers and functions. Gb3 expression level in one of these clones (referred to as FMEC2) was highly susceptible to culture media, and appeared to be regulated by glucosylceramide synthase. Results also showed that Gb3 could be upregulated by hydrocortisone. FMEC2 express the mannose 6-phosphate receptor and sortilin but not the mannose receptor. Uptake studies suggested that sortilin plays a role in the binding and internalization of mammalian cell-produced α-galactosidase A. Moss-aGal (a plant-made enzyme) was endocytosed by FMEC2 via a receptor other than the aforementioned receptors. In conclusion, this study suggests that glucosylceramide synthase and hydrocortisone may play important roles in modulating Gb3 levels in Fabry mouse aortic endothelial cells, and that endocytosis of recombinant α-galactosidase A involves a combination of multiple receptors depending on the properties of the enzyme.

摘要

法布里病由α-半乳糖苷酶A活性不足以及随后糖鞘脂(主要是Globotriaosylceramide,Gb3)在细胞内蓄积所致。血管内皮细胞可能在疾病发病机制中起重要作用,并且是治疗干预的主要靶细胞类型之一。在本研究中,我们从法布里病小鼠模型中生成了永生化主动脉内皮细胞系。这些细胞保留了内皮细胞特异性标志物和功能。其中一个克隆(称为FMEC2)中的Gb3表达水平对培养基高度敏感,并且似乎受葡萄糖神经酰胺合酶调控。结果还表明,氢化可的松可上调Gb3。FMEC2表达甘露糖6-磷酸受体和sortilin,但不表达甘露糖受体。摄取研究表明,sortilin在哺乳动物细胞产生的α-半乳糖苷酶A的结合和内化中起作用。Moss-aGal(一种植物制造的酶)通过上述受体以外的受体被FMEC2内吞。总之,本研究表明,葡萄糖神经酰胺合酶和氢化可的松可能在调节法布里病小鼠主动脉内皮细胞中Gb3水平方面起重要作用,并且重组α-半乳糖苷酶A的内吞作用取决于酶的性质,涉及多种受体的组合。

相似文献

1
Molecular basis for globotriaosylceramide regulation and enzyme uptake in immortalized aortic endothelial cells from Fabry mice.法布里病小鼠永生化主动脉内皮细胞中球三糖神经酰胺调节及酶摄取的分子基础。
J Inherit Metab Dis. 2016 May;39(3):447-455. doi: 10.1007/s10545-016-9920-6. Epub 2016 Mar 10.
2
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.甘露糖受体介导的苔藓制备的α-半乳糖苷酶A递送可有效纠正法布里病小鼠的酶缺乏症。
J Inherit Metab Dis. 2016 Mar;39(2):293-303. doi: 10.1007/s10545-015-9886-9. Epub 2015 Aug 27.
3
Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease.神经节苷脂 GM3 诱导法布里病内皮细胞中 KCa3.1 溶酶体降解
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):81-9. doi: 10.1161/ATVBAHA.113.302200. Epub 2013 Oct 24.
4
An in vitro model of Fabry disease.法布里病的体外模型。
J Am Soc Nephrol. 2005 Sep;16(9):2636-45. doi: 10.1681/ASN.2005040383. Epub 2005 Jul 20.
5
Mannose 6-phosphate receptor and sortilin mediated endocytosis of α-galactosidase A in kidney endothelial cells.甘露糖 6-磷酸受体和分选蛋白介导的肾脏内皮细胞中 α-半乳糖苷酶 A 的内吞作用。
PLoS One. 2012;7(6):e39975. doi: 10.1371/journal.pone.0039975. Epub 2012 Jun 29.
6
Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease.神经节苷脂 GM1 导致 K(Ca)3.1 通道功能障碍:法布里病内皮功能障碍的新认识。
Cardiovasc Res. 2011 Feb 1;89(2):290-9. doi: 10.1093/cvr/cvq333. Epub 2010 Oct 21.
7
Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.安德森-法布里病的发病机制和分子机制及可能的新分子靶向治疗策略。
Int J Mol Sci. 2021 Sep 18;22(18):10088. doi: 10.3390/ijms221810088.
8
Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease.法布里病患者人足细胞中 α-半乳糖苷酶 A 的受体介导内吞作用。
PLoS One. 2011;6(9):e25065. doi: 10.1371/journal.pone.0025065. Epub 2011 Sep 19.
9
Decreased nitric oxide bioavailability in a mouse model of Fabry disease.法布里病小鼠模型中一氧化氮生物利用度降低。
J Am Soc Nephrol. 2009 Sep;20(9):1975-85. doi: 10.1681/ASN.2008111190. Epub 2009 Jul 23.
10
Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice.在α-半乳糖苷酶A基因敲除小鼠的血管内皮细胞中,小窝蛋白相关的球三糖神经酰胺蓄积。
J Biol Chem. 2007 Jul 20;282(29):20960-7. doi: 10.1074/jbc.M702436200. Epub 2007 May 29.

本文引用的文献

1
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.甘露糖受体介导的苔藓制备的α-半乳糖苷酶A递送可有效纠正法布里病小鼠的酶缺乏症。
J Inherit Metab Dis. 2016 Mar;39(2):293-303. doi: 10.1007/s10545-015-9886-9. Epub 2015 Aug 27.
2
Blocking hyperactive androgen receptor signaling ameliorates cardiac and renal hypertrophy in Fabry mice.阻断过度活跃的雄激素受体信号传导可改善法布里病小鼠的心脏和肾脏肥大。
Hum Mol Genet. 2015 Jun 1;24(11):3181-91. doi: 10.1093/hmg/ddv070. Epub 2015 Feb 20.
3
α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease.
α-半乳糖苷酶 A 敲除小鼠:进行性器官病理学与 Fabry 病 2 型迟发性表型相似。
Am J Pathol. 2015 Mar;185(3):651-65. doi: 10.1016/j.ajpath.2014.11.004. Epub 2014 Dec 29.
4
Endothelial nitric oxide synthase uncoupling and microvascular dysfunction in the mesentery of mice deficient in α-galactosidase A.缺乏α-半乳糖苷酶 A 的小鼠肠系膜内皮型一氧化氮合酶解偶联和微血管功能障碍。
Am J Physiol Gastrointest Liver Physiol. 2014 Jan;306(2):G140-6. doi: 10.1152/ajpgi.00185.2013. Epub 2013 Nov 14.
5
Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.系统性递送葡萄糖神经酰胺合酶抑制剂可减少 2 型 Gaucher 病小鼠模型中的中枢神经系统底物并延长寿命。
PLoS One. 2012;7(8):e43310. doi: 10.1371/journal.pone.0043310. Epub 2012 Aug 17.
6
A shortcut to the lysosome: the mannose-6-phosphate-independent pathway.溶酶体的捷径:甘露糖-6-磷酸非依赖途径。
Mol Genet Metab. 2012 Nov;107(3):257-66. doi: 10.1016/j.ymgme.2012.07.012. Epub 2012 Jul 20.
7
Mannose 6-phosphate receptor and sortilin mediated endocytosis of α-galactosidase A in kidney endothelial cells.甘露糖 6-磷酸受体和分选蛋白介导的肾脏内皮细胞中 α-半乳糖苷酶 A 的内吞作用。
PLoS One. 2012;7(6):e39975. doi: 10.1371/journal.pone.0039975. Epub 2012 Jun 29.
8
Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.溶酶体递送治疗酶在法布里病的细胞模型中。
J Inherit Metab Dis. 2012 Nov;35(6):1107-17. doi: 10.1007/s10545-012-9472-3. Epub 2012 Mar 24.
9
The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cells.巨噬细胞甘露糖受体促进 ADAMTS13 被树突状细胞摄取。
Blood. 2012 Apr 19;119(16):3828-35. doi: 10.1182/blood-2011-09-377754. Epub 2012 Jan 30.
10
Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease.法布里病患者人足细胞中 α-半乳糖苷酶 A 的受体介导内吞作用。
PLoS One. 2011;6(9):e25065. doi: 10.1371/journal.pone.0025065. Epub 2011 Sep 19.